• S. P. Israëls
Part of the Developments in Hematology and Immunology book series (DIHI, volume 2)


Professor Forfar’s wide ranging review of Rhesus disease left out one aspect — something that has haunted me personally for some fifteen years. One of my own first patients with Rhesus antibodies and with complications, including anti-C, had a very high bilirubin. I had expected that an exchange transfusion would be carried out. But, the hospital — a university children’s hospital — advised that it was their practice to look only at the bilirubin. In this instance it was not indirect and not dangerous and they would not do an exchange transfusion for this child.


Citrate Heparin Bicarbonate Bilirubin Thrombin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Veall and Mollison, P. L.: Lancet, 2: 792, 1950PubMedCrossRefGoogle Scholar
  2. Mollison, P.L.: Blood transfusion in clinical medicine, 6th ed., Blackwell Scientific Publications, Oxford, 1979.Google Scholar
  3. Kevy, S.V.: Paediatric Transfusion Therapy. In: Transfusion Therapy,A.A.B.B., Washington, 1974.Google Scholar
  4. Kevy, S.V.: Personal Communication, 1 December 1976.Google Scholar
  5. Kevy, S.V.: Personal Communication, 30 September 1980.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1982

Authors and Affiliations

  • S. P. Israëls

There are no affiliations available

Personalised recommendations